176 related articles for article (PubMed ID: 19351113)
21. Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.
Lange JH; van Stuivenberg HH; Veerman W; Wals HC; Stork B; Coolen HK; McCreary AC; Adolfs TJ; Kruse CG
Bioorg Med Chem Lett; 2005 Nov; 15(21):4794-8. PubMed ID: 16140010
[TBL] [Abstract][Full Text] [Related]
22. Novel pyrazole derivatives as neutral CB₁ antagonists with significant activity towards food intake.
Manca I; Mastinu A; Olimpieri F; Falzoi M; Sani M; Ruiu S; Loriga G; Volonterio A; Tambaro S; Bottazzi ME; Zanda M; Pinna GA; Lazzari P
Eur J Med Chem; 2013 Apr; 62():256-69. PubMed ID: 23357307
[TBL] [Abstract][Full Text] [Related]
23. Optimization of imidazole amide derivatives as cannabinoid-1 receptor antagonists for the treatment of obesity.
Smith RA; Fathi Z; Achebe F; Akuche C; Brown SE; Choi S; Fan J; Jenkins S; Kluender HC; Konkar A; Lavoie R; Mays R; Natoli J; O'Connor SJ; Ortiz AA; Su N; Taing C; Tomlinson S; Tritto T; Wang G; Wirtz SN; Wong W; Yang XF; Ying S; Zhang Z
Bioorg Med Chem Lett; 2007 May; 17(10):2706-11. PubMed ID: 17383180
[TBL] [Abstract][Full Text] [Related]
24. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
[TBL] [Abstract][Full Text] [Related]
25. 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: design, synthesis, and neuropharmacological evaluation.
Abdel-Hafez AA; Abdel-Wahab BA
Bioorg Med Chem; 2008 Sep; 16(17):7983-91. PubMed ID: 18693017
[TBL] [Abstract][Full Text] [Related]
26. Novel pyrazole-3-carboxamide derivatives as cannabinoid-1 (CB1) antagonists: journey from non-polar to polar amides.
Sasmal PK; Reddy DS; Talwar R; Venkatesham B; Balasubrahmanyam D; Kannan M; Srinivas P; Kyasa SK; Devi BN; Jadhav VP; Khan SK; Mohan P; Chaudhury H; Bhuniya D; Iqbal J; Chakrabarti R
Bioorg Med Chem Lett; 2011 Jan; 21(1):562-8. PubMed ID: 21075633
[TBL] [Abstract][Full Text] [Related]
27. Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists.
Lange JH; Kruse CG
Drug Discov Today; 2005 May; 10(10):693-702. PubMed ID: 15896682
[TBL] [Abstract][Full Text] [Related]
28. Benzodioxoles: novel cannabinoid-1 receptor inverse agonists for the treatment of obesity.
Alig L; Alsenz J; Andjelkovic M; Bendels S; Bénardeau A; Bleicher K; Bourson A; David-Pierson P; Guba W; Hildbrand S; Kube D; Lübbers T; Mayweg AV; Narquizian R; Neidhart W; Nettekoven M; Plancher JM; Rocha C; Rogers-Evans M; Röver S; Schneider G; Taylor S; Waldmeier P
J Med Chem; 2008 Apr; 51(7):2115-27. PubMed ID: 18335976
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in the research and development of CB1 antagonists.
Smith RA; Fathi Z
IDrugs; 2005 Jan; 8(1):53-66. PubMed ID: 15650943
[TBL] [Abstract][Full Text] [Related]
30. Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists.
Lange JH; Attali A; van der Neut MA; Wals HC; Mulder A; Zilaout H; Duursma A; van Aken HH; van Vliet BJ
Bioorg Med Chem Lett; 2010 Sep; 20(17):4992-8. PubMed ID: 20688519
[TBL] [Abstract][Full Text] [Related]
31. Identification and hit-to-lead optimization of a novel class of CB1 antagonists.
Letourneau JJ; Jokiel P; Olson J; Riviello CM; Ho KK; McAleer L; Yang J; Swanson RN; Baker J; Cowley P; Edwards D; Ward N; Ohlmeyer MH; Webb ML
Bioorg Med Chem Lett; 2010 Sep; 20(18):5449-53. PubMed ID: 20719511
[TBL] [Abstract][Full Text] [Related]
32. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
Cowley PM; Baker J; Barn DR; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Goodwin RR; Jaap D; Kiyoi Y; Mort C; Palin R; Prosser A; Walker G; Ward N; Wishart G; Young T
Bioorg Med Chem Lett; 2011 Jan; 21(1):497-501. PubMed ID: 21075628
[TBL] [Abstract][Full Text] [Related]
33. CB1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders.
Antel J; Gregory PC; Nordheim U
J Med Chem; 2006 Jul; 49(14):4008-16. PubMed ID: 16821760
[No Abstract] [Full Text] [Related]
34. Substituted pyrimidines as cannabinoid CB1 receptor ligands.
Kim MJ; Kim JY; Seo HJ; Lee J; Lee SH; Kim MS; Kang J; Kim J; Lee J
Bioorg Med Chem Lett; 2009 Aug; 19(16):4692-7. PubMed ID: 19596576
[TBL] [Abstract][Full Text] [Related]
35. Novel thioamide derivatives as neutral CB1 receptor antagonists.
Boström J; Olsson RI; Tholander J; Greasley PJ; Ryberg E; Nordberg H; Hjorth S; Cheng L
Bioorg Med Chem Lett; 2010 Jan; 20(2):479-82. PubMed ID: 20005704
[TBL] [Abstract][Full Text] [Related]
36. Studies of cannabinoid-1 receptor antagonists for the treatment of obesity: hologram QSAR model for biarylpyrazolyl oxadiazole ligands.
Ye M; Dawson MI
Bioorg Med Chem Lett; 2009 Jun; 19(12):3310-5. PubMed ID: 19427207
[TBL] [Abstract][Full Text] [Related]
37. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
[TBL] [Abstract][Full Text] [Related]
38. Scaffold hopping, synthesis and structure-activity relationships of 5,6-diaryl-pyrazine-2-amide derivatives: a novel series of CB1 receptor antagonists.
Boström J; Berggren K; Elebring T; Greasley PJ; Wilstermann M
Bioorg Med Chem; 2007 Jun; 15(12):4077-84. PubMed ID: 17433696
[TBL] [Abstract][Full Text] [Related]
39. Constrained analogs of CB-1 antagonists: 1,5,6,7-Tetrahydro-4H-pyrrolo[3,2-c]pyridine-4-one derivatives.
Smith RA; Fathi Z; Brown SE; Choi S; Fan J; Jenkins S; Kluender HC; Konkar A; Lavoie R; Mays R; Natoli J; O'Connor SJ; Ortiz AA; Podlogar B; Taing C; Tomlinson S; Tritto T; Zhang Z
Bioorg Med Chem Lett; 2007 Feb; 17(3):673-8. PubMed ID: 17107792
[TBL] [Abstract][Full Text] [Related]
40. Discovery of cannabinoid-1 receptor antagonists by virtual screening.
Lee GN; Kim KR; Ahn SH; Bae MA; Kang NS
Bioorg Med Chem Lett; 2010 Sep; 20(17):5130-2. PubMed ID: 20667724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
